Zacks: Analysts Anticipate Caretrust REIT Inc (CTRE) Will Post Quarterly Sales of $39.64 Million
Equities analysts predict that Caretrust REIT Inc (NASDAQ:CTRE) will report sales of $39.64 million for the current fiscal quarter, according to Zacks Investment Research. Two analysts have made estimates for Caretrust REIT’s earnings, with the lowest sales estimate coming in at $39.28 million and the highest estimate coming in at $40.00 million. Caretrust REIT reported sales of $32.95 million during the same quarter last year, which would suggest a positive year-over-year growth rate of 20.3%. The firm is expected to announce its next quarterly earnings results on Wednesday, November 14th.
According to Zacks, analysts expect that Caretrust REIT will report full year sales of $157.24 million for the current fiscal year, with estimates ranging from $155.91 million to $158.80 million. For the next financial year, analysts anticipate that the firm will report sales of $175.43 million per share, with estimates ranging from $160.00 million to $183.30 million. Zacks’ sales calculations are an average based on a survey of sell-side research analysts that follow Caretrust REIT.
Caretrust REIT (NASDAQ:CTRE) last released its earnings results on Wednesday, August 1st. The real estate investment trust reported $0.17 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.17. The firm had revenue of $38.97 million during the quarter, compared to the consensus estimate of $38.44 million. Caretrust REIT had a return on equity of 6.81% and a net margin of 28.26%. The firm’s revenue for the quarter was up 18.7% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.30 earnings per share.
CTRE opened at $18.50 on Wednesday. The company has a market capitalization of $1.49 billion, a price-to-earnings ratio of 15.95, a PEG ratio of 2.86 and a beta of 0.78. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.65 and a quick ratio of 1.65. Caretrust REIT has a 1-year low of $12.73 and a 1-year high of $19.82.
Several hedge funds and other institutional investors have recently bought and sold shares of CTRE. Mount Yale Investment Advisors LLC bought a new position in shares of Caretrust REIT in the first quarter valued at $114,000. Brown Advisory Inc. bought a new position in shares of Caretrust REIT in the first quarter valued at $135,000. SG Americas Securities LLC increased its holdings in shares of Caretrust REIT by 83.6% in the first quarter. SG Americas Securities LLC now owns 12,555 shares of the real estate investment trust’s stock valued at $168,000 after buying an additional 5,716 shares in the last quarter. Meeder Asset Management Inc. increased its holdings in shares of Caretrust REIT by 1,209.3% in the second quarter. Meeder Asset Management Inc. now owns 10,592 shares of the real estate investment trust’s stock valued at $177,000 after buying an additional 9,783 shares in the last quarter. Finally, Gagnon Securities LLC bought a new position in shares of Caretrust REIT in the second quarter valued at $201,000. 88.06% of the stock is currently owned by institutional investors.
Caretrust REIT Company Profile
CareTrust REIT, Inc is a self-administered, publicly-traded real estate investment trust engaged in the ownership, acquisition and leasing of seniors housing and healthcare-related properties. With 189 net-leased healthcare properties and three operated seniors housing properties in 25 states, CareTrust REIT is pursuing opportunities across the nation to acquire properties that will be leased to a diverse group of local, regional and national seniors housing operators, healthcare services providers, and other healthcare-related businesses.
Further Reading: Short Selling
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Caretrust REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Caretrust REIT and related companies with MarketBeat.com's FREE daily email newsletter.